PTN PALATIN TECHNOLOGIES INC
Pharmaceutical Preparations · Nasdaq · SEC CIK 911216 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-276.9%
TTM EPS YoY-4.0%
Revenue 3-yr CAGR-61.6%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-5,354.1%
Net margin-5,261.5%
FCF margin—
EBITDA margin-5,335.2%
Returns
ROE-1,495.4%
ROA-271.7%
ROIC (approx.)—
Asset turnover0.05x
Leverage & solvency
Liabilities / assets57.1%
Debt / equity0.00x
Current ratio1.67x
Interest coverage-2,873.67x
Cash quality & payout
Operating cash flow / net income0.86x
Accruals ratio-36.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 |
|---|---|---|
| Income statement | ||
| Revenue | $8.83M | $0 |
| R&D expense | $12.37M | $14.90M |
| SG&A expense | $9.48M | $7.81M |
| Operating income | -$8.67M | -$17.46M |
| Interest expense | $6,726 | $15,025 |
| Income tax | -$8.38M | -$17.31M |
| Net income | -$8.38M | -$17.31M |
| EBITDA | -$8.61M | -$17.20M |
| EPS (basic) | -2.96 | -32.15 |
| EPS (diluted) | -2.96 | -32.15 |
| Weighted avg. shares (diluted) | 2.83M | 538,348 |
| Balance sheet | ||
| Cash & equivalents | $7.49M | $9.53M |
| Receivables | $300,770 | $0 |
| Current assets | $8.16M | $2.92M |
| PP&E, net | $118,064 | $129,444 |
| Total assets | $8.52M | $3.27M |
| Current liabilities | $1.77M | $8.01M |
| Total liabilities | $1.84M | $8.04M |
| Shareholders' equity | $6.69M | -$4.78M |
| Shares outstanding | 1.78M | 929,597 |
| Cash flow statement | ||
| Operating cash flow | -$13.53M | -$21.31M |
| Capital expenditure | $51,299 | $0 |
| Free cash flow | -$13.58M | -$21.31M |
| Investing cash flow | -$51,299 | $3.13M |
| Financing cash flow | $18.51M | $11.21M |
| Depreciation & amortization | $62,679 | $258,917 |
| Stock-based compensation | $1.33M | $1.38M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.